Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives

References

• Multiple Sclerosis International Federation. What is MS? Multiple sclerosis (MS) is a progressive disease of the nervous system; 2019. Available from: https://www.msif.org/about-ms/what-is-ms/. Accessed December 5, 2020.
   Google Scholar
• Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis. Neurology. 2014;83(3):278–286. doi:10.1212/WNL.0000000000000560
   Web of Science ®Google Scholar
• Chataway J. Tackling progression in multiple sclerosis. Lancet Neurol. 2018;17(6):489–491. doi:10.1016/S1474-4422(18)30158-3
   Web of Science ®Google Scholar
• Faissner S, Gold R. Progressive multiple sclerosis: latest therapeutic developments and future directions. Ther Adv Neurol Disord. 2019;12:1756286419878323. doi:10.1177/1756286419878323
   Web of Science ®Google Scholar
• Stankiewicz JM, Weiner HL. An argument for broad use of high efficacy treatments in early multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2020;7(1):e636. doi:10.1212/NXI.0000000000000636
   Google Scholar
• Filippi M, Preziosa P, Langdon D, et al. Identifying progression in multiple sclerosis: new perspectives. Ann Neurol. 2020;88(3):438–452. doi:10.1002/ana.25808
   PubMed Web of Science ®Google Scholar
• Ghafari S, Fallahi-Khoshknab M, Nourozi K, Mohammadi E. Patients’ experiences of adapting to multiple sclerosis: a qualitative study. Contemporary Nurse. 2015;50(1):36–49. doi:10.1080/10376178.2015.1010252
   PubMed Web of Science ®Google Scholar
• Frost J, Grose J, Britten N. A qualitative investigation of lay perspectives of diagnosis and self-management strategies employed by people with progressive multiple sclerosis. Health. 2017;21(3):316–336. doi:10.1177/1363459316674787
   PubMed Web of Science ®Google Scholar
• Cadden MH, Arnett PA, Tyry TM, Cook JE. Judgment hurts: the psychological consequences of experiencing stigma in multiple sclerosis. Soc Sci Med. 2018;208:158–164. doi:10.1016/j.socscimed.2018.01.015
   PubMed Web of Science ®Google Scholar
• Pérez-Miralles F, Prefasi D, García-Merino A, et al. Perception of stigma in patients with primary progressive multiple sclerosis. Mult Scler J Exp Transl Clin. April 2019. doi:10.1177/2055217319852717
   Google Scholar
• Greenberg B, Fan Y, Carriere L, Sullivan A. Depression and age at first neurology appointment associated with receipt of behavioral medicine services within 1 year in a multiple sclerosis population. Int J MS Care. 2017;19(4):199–207. doi:10.7224/1537-2073.2016-012
   Google Scholar
• Butler E, Thomas R, Carolan A, Silber E, Chalder T. ‘It’s the unknown’ – understanding anxiety: from the perspective of people with multiple sclerosis. Psychol Health. 2019;34(3):368–383. doi:10.1080/08870446.2018.1541989
   PubMed Web of Science ®Google Scholar
• Rieckmann P, Centonze D, Elovaara I, et al. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: a combined perspective from the MS in the 21st Century Steering Group. Mult Scler Relat Disord. 2018;19:153–160. doi:10.1016/j.msard.2017.11.013
   PubMed Web of Science ®Google Scholar
• Colligan E, Metzler A, Tiryaki E. Shared decision-making in multiple sclerosis. Mult Scler. 2017;23(2):185–190. doi:10.1177/1352458516671204
   PubMed Web of Science ®Google Scholar
• Burtchell J, Fetty K, Miller K, Minden K, Kantor D. Two sides to every story: perspectives from four patients and a healthcare professional on multiple sclerosis disease progression. Neurol Ther. 2019;8(2):185–205. doi:10.1007/s40120-019-0141-4
   PubMed Web of Science ®Google Scholar
• Davies F, Edwards A, Brain K, et al. ‘You are just left to get on with it’: qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis. BMJ Open. 2015;5(7):e007674. doi:10.1136/bmjopen-2015-007674
   PubMed Web of Science ®Google Scholar
• Goretti B, Portaccio E, Zipoli V, Razzolini L, Amato MP. Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci. 2010;31(Suppl 2):S227–230. doi:10.1007/s10072-010-0372-8
   Web of Science ®Google Scholar
• Dahdaleh M, Alroughani R, Aljumah M, et al. Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet? Int J Neurosci. 2017;127(10):944–951. doi:10.1080/00207454.2016.1277424
   PubMed Web of Science ®Google Scholar
• Inojosa H, Proschmann U, Akgün K, Ziemssen T. A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition. J Neurol. 2019. Online ahead of print. doi:10.1007/s00415-019-09489-5
   PubMed Web of Science ®Google Scholar
• Matza LS, Kim K, Phillips G, et al. Multiple sclerosis relapse: qualitative findings from clinician and patient interviews. Mult Scler Relat Disord. 2019;27:139–146. doi:10.1016/j.msard.2018.09.029
   PubMed Web of Science ®Google Scholar
• Solari A, Giovannetti AM, Giordano A, et al. Conversion to secondary progressive multiple sclerosis: patient awareness and needs. Results from an online survey in Italy and Germany. Front Neurol. 2019;10:916. doi:10.3389/fneur.2019.00916
   Web of Science ®Google Scholar
• de Seze J, Borgel F, Brudon F. Patient perceptions of multiple sclerosis and its treatment. Patient Prefer Adherence. 2012;6:263–273. doi:10.2147/PPA.S27038
   PubMed Web of Science ®Google Scholar
• Soundy A, Benson J, Dawes H, Smith B, Collett J, Meaney A. Understanding hope in patients with multiple sclerosis. Physiotherapy. 2012;98(4):349–355. doi:10.1016/j.physio.2011.05.003
   Web of Science ®Google Scholar
• Koffman J, Gao W, Goddard C, et al. Progression, symptoms and psychosocial concerns among those severely affected by multiple sclerosis: a mixed-methods cross-sectional study of black Caribbean and white British people. PLoS One. 2013;8(10):e75431. doi:10.1371/journal.pone.0075431
   PubMed Web of Science ®Google Scholar
• Lee Mortensen G, Rasmussen PV. The impact of quality of life on treatment preferences in multiple sclerosis patients. Patient Prefer Adherence. 2017;11:1789–1796. doi:10.2147/PPA.S142373
   PubMed Web of Science ®Google Scholar
• Feinstein A, Pavisian B. Multiple sclerosis and suicide. Mult Scler J. 2017;23(7):923–927. doi:10.1177/1352458517702553
   PubMed Web of Science ®Google Scholar
• Malcomson KS, Lowe-Strong AS, Dunwoody L. What can we learn from the personal insights of individuals living and coping with multiple sclerosis? Disabil Rehabil. 2008;30(9):662–674. doi:10.1080/09638280701400730
   PubMed Web of Science ®Google Scholar
• Król J, Szcześniak M, Koziarska D, Rzepa T. Time perception and illness acceptance among remitting-relapsing multiple sclerosis patients under treatment. Psychiatr Pol. 2015;49(5):911–920. doi:10.12740/PP/38740
   PubMed Web of Science ®Google Scholar
• Dennison L, Brown M, Kirby S, Galea I. Do people with multiple sclerosis want to know their prognosis? A UK nationwide study. PLoS One. 2018;13(2):e0193407. doi:10.1371/journal.pone.0193407
   PubMed Web of Science ®Google Scholar
• Buecken R, Galushko M, Golla H, et al. Patients feeling severely affected by multiple sclerosis: how do patients want to communicate about end-of-life issues? Patient Educ Couns. 2012;88(2):318–324. doi:10.1016/j.pec.2012.03.010
   Web of Science ®Google Scholar
• Dennison L, McCloy Smith E, Bradbury K,Galea I. How do people with multiple sclerosis experience prognostic uncertainty and prognosis communication? A qualitative study. PLoS One. 2016;11(7):e0158982. doi:10.1371/journal.pone.0158982
   PubMed Web of Science ®Google Scholar
• Chesi P, Marini MG, Mancardi GL, et al. Listening to the neurological teams for multiple sclerosis: the SMART project. Neurol Sci. 2020;2231–2240. doi:10.1007/s10072-020-04301-z
   Web of Science ®Google Scholar
• O’Loughlin E, Hourihan S, Chataway J, Playford ED, Riazi A. The experience of transitioning from relapsing remitting to secondary progressive multiple sclerosis: views of patients and health professionals. Disabil Rehabil. 2017;39(18):1821–1828. doi:10.1080/09638288.2016.1211760
   PubMed Web of Science ®Google Scholar
• The Health Foundation. Person-Centred Care Made Simple: What Everyone Should Know About Person-Centred Care. Available from: https://www.health.org.uk/publications/person-centred-care-made-simple. Accessed December 17, 2020. 2014.
   Google Scholar
• Methley AM, Chew-Graham CA, Cheraghi-Sohi S, Campbell SM. A qualitative study of patient and professional perspectives of healthcare services for multiple sclerosis: implications for service development and policy. Health Soc Care Community. 2017;25(3):848–857. doi:10.1111/hsc.12369
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Multiple sclerosis in adults: management. Clinical guideline [CG186]. Available from: https://www.nice.org.uk/guidance/cg186. Accessed December 5, 2020. 2019.
   Google Scholar
• Visser LH, Heerings MA, Jongen PJ, van der Hiele K. Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment. Patient Prefer Adherence. 2016;10:659–667. doi:10.2147/PPA.S106155
   Web of Science ®Google Scholar
• Col NF, Solomon AJ, Springmann V, et al. Whose preferences matter? A patient-centered approach for eliciting treatment goals. Med Decis Mak. 2018;38(1):44–55. doi:10.1177/0272989X17724434
   PubMed Web of Science ®Google Scholar
• Buesa-Estelléz A, Cano-de-la-Cuerda R, Ortiz-Gutiérrez RM, Palacios-Ceña D. The impact of pharmacological treatment on patients with multiple sclerosis. Disabil Health J. 2019;12(4):615–621. doi:10.1016/j.dhjo.2019.05.005
   Web of Science ®Google Scholar
• Riñon A, Buch M, Holley D, Verdun E. The MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosis. Patient Prefer Adherence. 2011;5:629–643. doi:10.2147/PPA.S26479.
   PubMed Web of Science ®Google Scholar
• de Ceuninck van Capelle A, van der Meide H, Vosman FJH, Visser LH. A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT’s) in multiple sclerosis (MS). PLoS One. 2017;12(8):e0182806. doi:10.1371/journal.pone.0182806
   Web of Science ®Google Scholar
• Department of Health and Social Care. Long term conditions compendium of information: third edition. Avialble from: https://www.gov.uk/government/publications/long-term-conditions-compendium-of-information-third-edition. Accessed December 5, 2020.2012.
   Google Scholar
• Berger O, Grønberg BH, Loge JH, Kaasa S, Sand K. Cancer patients’ knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study. BMC Cancer. 2018;18(1):381. doi:10.1186/s12885-018-4164-5
   Web of Science ®Google Scholar
• Bužgová R, Kozáková R. Informing patients with progressive neurological disease of their health status, and their adaptation to the disease. BMC Neurol. 2019;19(1):250. doi:10.1186/s12883-019-1488-y
   Web of Science ®Google Scholar
• Brown VA, Parker PA, Furber L, Thomas AL. Patient preferences for the delivery of bad news - the experience of a UK Cancer Centre. Eur J Cancer Care (Engl). 2011;20(1):56–61. doi:10.1111/j.1365-2354.2009.01156.x
   PubMed Web of Science ®Google Scholar
• Mirza RD, Ren M, Agarwal A, Guyatt GH. Assessing patient perspectives on receiving bad news: a survey of 1337 patients with life-changing diagnoses. AJOB Empir Bioeth. 2019;10(1):36–43. doi:10.1080/23294515.2018.1543218
   PubMedGoogle Scholar
• Friedrichsen MJ, Strang PM, Carlsson ME. Breaking bad news in the transition from curative to palliative cancer care – patient’s view of the doctor giving the information. Support Care Cancer. 2000;8(6):472–478.
   Web of Science ®Google Scholar
• McCluskey L, Casarett D, Siderowf A. Breaking the news: a survey of ALS patients and their caregivers. Amyotrophic Lateral Sclerosis Motor Neuron Dis. 2004;5(3):131–135. doi:10.1080/14660820410020772
   PubMed Web of Science ®Google Scholar
• Yardley SJ, Davis CL, Sheldon F. Receiving a diagnosis of lung cancer: patients‘ interpretations, perceptions and perspectives. Palliat Med. 2001;15(5):379–386. doi:10.1191/026921601680419429
   Web of Science ®Google Scholar
• Selman LE, Bristowe K, Higginson IJ, Murtagh FEM. The views and experiences of older people with conservatively managed renal failure: a qualitative study of communication, information and decision-making. BMC Nephrology. 2019;20(1):38. doi:10.1186/s12882-019-1230-4
   Web of Science ®Google Scholar
• Hagerty RG, Butow PN, Ellis PA, et al. Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol. 2004;22(9):1721–1730. doi:10.1200/JCO.2004.04.095
   PubMed Web of Science ®Google Scholar
• Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91. doi:10.3389/fphar.2013.00091
   PubMed Web of Science ®Google Scholar
• Pagès-Puigdemont N, Mangues MA, Masip M, et al. Patients’ perspective of medication adherence in chronic conditions: a qualitative study. Adv Ther. 2016;33(10):1740–1754. doi:10.1007/s12325-016-0394-6
   PubMed Web of Science ®Google Scholar
• Kähkönen O, Kyngäs H, Saaranen T, Kankkunen P, Miettinen H, Oikarinen A. Support from next of kin and nurses are significant predictors of long-term adherence to treatment in post-PCI patients. Eur J Cardiovasc Nurs. 2020;19(4):339–350. doi:10.1177/1474515119887851
   PubMed Web of Science ®Google Scholar
• Islam SMS, Biswas T, Bhuiyan FA, Mustafa K, Islam A. Patients’ perspective of disease and medication adherence for type 2 diabetes in an urban area in Bangladesh: a qualitative study. BMC Res Notes. 2017;10(1):131. doi:10.1186/s13104-017-2454-7
   PubMedGoogle Scholar
• Buiting HM, van Ark MAC, Dethmers O, Maats EPE, Stoker JA, Sonke GS. Complex challenges for patients with protracted incurable cancer: an ethnographic study in a comprehensive cancer centre in the Netherlands. BMJ Open. 2019;9(3):e024450. doi:10.1136/bmjopen-2018-024450
   Web of Science ®Google Scholar
• Clayton JM, Butow PN, Arnold RM, Tattersall MHN. Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer. 2005;103(9):1965–1975. doi:10.1002/cncr.21011
   PubMed Web of Science ®Google Scholar
• Calderón-Larrañaga A, Vetrano DL, Welmer A-K, Grande G, Fratiglioni L, Dekhtyar S. Psychological correlates of multimorbidity and disability accumulation in older adults. Age Ageing. 2019;48(6):789–796. doi:10.1093/ageing/afz117
   Web of Science ®Google Scholar
• Dunn P, Conard S. Improving health literacy in patients with chronic conditions: a call to action. Int J Cardiol. 2018;273:249–251. doi:10.1016/j.ijcard.2018.08.090
   Web of Science ®Google Scholar
• Tran V-T, Riveros C, Péan C, Czarnobroda A, Ravaud P. Patients’ perspective on how to improve the care of people with chronic conditions in France: a citizen science study within the ComPaRe e-cohort. BMJ Quality Safety. 2019;28(11):875-886. doi:10.1136/bmjqs-2018-008593
   Web of Science ®Google Scholar
• Vermersch P, Shanahan J, Langdon D, Yeandle D, Alexandri N, Knowledgeis power, but is ignorance bliss? Optimising conversations about disease progression in multiple sclerosis. Neurol Ther. 2020;9(1):1–10. doi:10.1007/s40120-019-00170-7
   Web of Science ®Google Scholar
• Webb EJD, Meads D, Eskyte I, et al. A systematic review of discrete-choice experiments and conjoint analysis studies in people with multiple sclerosis. Patient. 2018;11(4):391–402. doi:10.1007/s40271-017-0296-y
   PubMedGoogle Scholar
• Hayter AL, Salkovskis PM, Silber E, Morris RG. The impact of health anxiety in patients with relapsing remitting multiple sclerosis: misperception, misattribution and quality of life. Br J Clin Psychol. 2016;55(4):371–386. doi:10.1111/bjc.12106
   PubMed Web of Science ®Google Scholar
• Kirk S, Hinton D. “I’m not what I used to be”: a qualitative study exploring how young people experience being diagnosed with a chronic illness. Child Care Health Dev. 2019;45(2):216–226. doi:10.1111/cch.12638
   PubMed Web of Science ®Google Scholar
• Bury M. Chronic illness as biographical disruption. Sociol Health Illn. 1982;4(2):167–182. doi:10.1111/1467-9566.ep11339939
   PubMedGoogle Scholar
• Hickey JV. Good communication with healthcare providers helped patients with multiple sclerosis to cope and adapt. Evid Based Nurs. 2004;7(4):124. doi:10.1136/ebn.7.4.124
   Google Scholar
• Alroughani RA. Improving communication with multiple sclerosis patients. Neurosciences. 2015;20(2):95–97. doi:10.17712/nsj.2015.2.20140441
   Web of Science ®Google Scholar
• Tintoré M, Alexander M, Costello K, et al. The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction. Patient Prefer Adherence. 2016;11:33–45. doi:10.2147/PPA.S115090
   Web of Science ®Google Scholar
• Schlegel V, Leray E. From medical prescription to patient compliance: a qualitative insight into the neurologist–patient relationship in multiple sclerosis. Int J MS Care. 2018;20(6):279–286. doi:10.7224/1537-2073.2017-043
   Google Scholar
• Chiò A, Domenico Borasio G. Breaking the news in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(4):195–201. doi:10.1080/14660820310017326
   PubMed Web of Science ®Google Scholar
• Watz H, Barnacle H, Hartley BF, Chan R. Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2014;2(1):63–72. doi:10.1016/S2213-2600(13)70200-5
   PubMed Web of Science ®Google Scholar
• Beiki O, Frumento P, Bottai M, Manouchehrinia A, Hillert J. Changes in the risk of reaching multiple sclerosis disability milestones in recent decades: a nationwide population-based cohort study in Sweden. JAMA Neurol. 2019;76(6):665–671. doi:10.1001/jamaneurol.2019.0330
   PubMed Web of Science ®Google Scholar
• Adler AI, Knight H. Ocrelizumab for primary progressive multiple sclerosis. Lancet Neurol. 2019;18(9):816–817. doi:10.1016/S1474-4422(19)30245-5
   PubMed Web of Science ®Google Scholar
• Manzano A, Eskytė I, Ford HL, et al. Impact of communication on first treatment decisions in people with relapsing-remitting multiple sclerosis. Patient Educ Couns. 2020;103(12):2540–2547. doi:10.1016/j.pec.2020.05.014
   Web of Science ®Google Scholar
• Maskrey N. Shared decision making: why the slow progress? An essay by Neal Maskrey. BMJ. 2019;367:l6762. doi:10.1136/bmj.l6762
   PubMed Web of Science ®Google Scholar
• Brashear A, Vickrey BG. Burnout in neurology. Extinguishing the embers and rekindling the joy in practice. Neurology. 2018;91(20):907-908. doi:10.1212/WNL.0000000000006520
   Web of Science ®Google Scholar
• Ploughman M, Austin MW, Murdoch M, et al. Factors influencing healthy aging with multiple sclerosis: a qualitative study. Disabil Rehabil. 2012;34(1):26–33. doi:10.3109/09638288.2011.585212
   PubMed Web of Science ®Google Scholar
• Wilski M, Tasiemski T. Illness perception, treatment beliefs, self-esteem, and self-efficacy as correlates of self-management in multiple sclerosis. Acta Neurol Scand. 2016;133(5):338–345. doi:10.1111/ane.12465
   PubMed Web of Science ®Google Scholar
• Kragt JJ, Nielsen JM, van der Linden FAH, Polman CH, Uitdehaag BMJ. Disease progression in multiple sclerosis: combining physicians’ and patients’ perspectives? Mult Scler J. 2010;17(2):234–240. doi:10.1177/1352458510385505
   Web of Science ®Google Scholar
• Synnot AJ, Hill SJ, Garner KA, et al. Online health information seeking: how people with multiple sclerosis find, assess and integrate treatment information to manage their health. Heal Expect. 2016;19(3):727–737. doi:10.1111/hex.12253
   PubMed Web of Science ®Google Scholar
• Kantor D, Bright JR, Burtchell J. Perspectives from the patient and the healthcare professional in multiple sclerosis: social media and participatory medicine. Neurol Ther. 2018;7(1):37–49. doi:10.1007/s40120-017-0088-2
   PubMed Web of Science ®Google Scholar
• Marziniak M, Brichetto G, Feys P, Meyding-Lamadé U, Vernon K, Meuth SG. The use of digital and remote communication technologies as a tool for multiple sclerosis management: narrative review. JMIR Rehabil Assist Technol. 2018;5(1):e5. doi:10.2196/rehab.7805
   PubMedGoogle Scholar
• Salimzadeh Z, Damanabi S, Kalankesh LR, Ferdousi R. Mobile applications for multiple sclerosis: a focus on self-management. Acta Inform Med. 2019;27(1):12–18. doi:10.5455/aim.2019.27.12-18
   PubMedGoogle Scholar
• Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology. 2009;62(10). doi:10.1136/bmj.b2700
   Google Scholar